430 top medical experts on Pulmonary Alveolar Proteinosis across 44 countries and 28 U.S. states, including 269 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Pulmonary Alveolar Proteinosis: A pulmonary alveoli-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and dyspnea. This disease is often related to, congenital or acquired, impaired processing of pulmonary surfactants by alveolar macrophages, a process dependent on granulocyte-macrophage colony-stimulating factor.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Lung Diseases (3,785).
  4. Clinical Trials ClinicalTrials.gov : at least 26 including 14 Completed, 4 Recruiting


  

        

                    


    Computing Expert Listing ...

);